Oral Contraceptives
Reports claiming non-procurement of contraceptives misleading: Govt
The Union Health Ministry Tuesday termed "misleading" reports claiming that India's family planning programme is likely to get severely affected due to the country's central procurement agency's failure in procuring contraceptives. "Such reports are ill-informed and provides misleading information," the ministry said in a statement. The Central Medical Services Society (CMSS), an autonomous body and a Central Procurement Agency under Union Ministry of Health, procures condoms for National Family Planning Programme and National AIDS Control Programme. "The CMSS procured 5.88 crores pieces of condoms for Family Planning Programme in May, 2023 and the present stock position of condoms is sufficient to meet the requirement of the Family Planning Programme," the ministry said. Currently, National Aids Control Organization (NACO) is receiving supplies of 75 per cent free condoms from M/s HLL Lifecare Ltd. and is preparing to place remaining 25 per cent quantities for 2023-24 with CMSS on
 "Reports claiming non-procurement of contraceptives misleading: Govt")
Lupin recalls 4,113 cartons of oral contraceptive medicine in US market
Homegrown drug maker Lupin is recalling 4,113 cartons of generic oral contraceptive tablets in the US, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Lupin's US-based unit is recalling 4,113 cartons of Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg). The affected lot has been produced at the company's Pithampur-based manufacturing facility in Madhya Pradesh and distributed in the US by Baltimore-based Lupin Pharmaceuticals, Inc. The company is recalling the lot due to it being Subpotent Drug, the US health regulator noted in the report. Lupin initiated the nationwide recall on November 19 this year, it added. The USFDA has classified both the recalls as class III. As per the US health regulator, a class III recall is initiated in a situation in which use of, or exposure to, a .
 "Lupin recalls 4,113 cartons of oral contraceptive medicine in US market")
Buying birth control pills online may be safe and efficient, says study
Experts have been concerned about the quality of services provided by online vendors
 "Buying birth control pills online may be safe and efficient, says study")
Oral contraceptives may lower risk of serious knee injuries in women: Study
ACL injuries are extremely common, especially among the young athletic population, and are two to eight times more common in women than men
 "Oral contraceptives may lower risk of serious knee injuries in women: Study")
